Dynamics of the cytotoxic T cell response to a model of acute viral infection

Journal of Virology

Volumn 89, Issue 8, 2015, Pages 4517-4526

  DeWitt, William S ^a   Emerson, Ryan O ^a   Lindau, Paul ^b,c   Vignali, Marissa ^a   Snyder, Thomas M ^a   Desmarais, Cindy ^a   Sanders, Catherine ^a   Utsugi, Heidi ^b   Warren, Edus H ^b   McElrath, Juliana ^b   Makar, Karen W ^b   Wald, Anna ^c   Robins, Harlan S ^a,b  

^a ADAPTIVE BIOTECHNOLOGIES   (United States)

^b USA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; LIVE ATTENUATED YELLOW FEVER VIRUS VACCINE; LIVE VACCINE; T LYMPHOCYTE RECEPTOR BETA CHAIN; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADULT; ALGORITHM; ARTICLE; CD8+ T LYMPHOCYTE; CELL SELECTION; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DNA EXTRACTION; DYNAMICS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOLOGICAL MEMORY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; VACCINATION; VIRUS INFECTION; YELLOW FEVER FLAVIVIRUS; CELL LINEAGE; DNA SEQUENCE; FLOW CYTOMETRY; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; UNITED STATES; YELLOW FEVER VIRUS;

YELLOW FEVER VIRUS;

BASE SEQUENCE; CELL LINEAGE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC MEMORY; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, ATTENUATED; VIRAL VACCINES; WASHINGTON; YELLOW FEVER VIRUS;

EID: 84925400635     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03474-14     Document Type: Article

References (42)

1. Kaech SM, Wherry EJ. 2007. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 27:393-405. http://dx.doi.org/10.1016/j.immuni.2007.08.007.
2. Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V, Subramaniam S, Blattman JN, Barber DL, Ahmed R. 2007. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27:670-684. http://dx.doi.org/10.1016/j.immuni.2007.09.006.
3. Engel I, Hedrick SM. 1988. Site-directed mutations in the VDJ junctional region of a T cell receptor beta chain cause changes in antigenic peptide recognition. Cell 54:473-484. http://dx.doi.org/10.1016/0092-8674(88)90068-2.
4. Jorgensen JL, Esser U, Fazekas de St Groth B, Reay PA, Davis MM. 1992. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 355:224-230. http://dx.doi.org/10.1038/355224a0.
5. McHeyzer-Williams MG, Davis MM. 1995. Antigen-specific development of primary and memory T cells in vivo. Science 268:106-111. http://dx.doi.org/10.1126/science.7535476.
6. Miller JD, van der Most RG, Akondy RS, Glidewell JT, Albott S, Masopust D, Murali-Krishna K, Mahar PL, Edupuganti S, Lalor S, Germon S, Del Rio C, Mulligan MJ, Staprans SI, Altman JD, Feinberg MB, Ahmed R. 2008. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity 28:710-722. http://dx.doi.org/10.1016/j.immuni.2008.02.020.
7. Newell EW, Sigal N, Bendall SC, Nolan GP, Davis MM. 2012. Cytometry by time-of-flight shows combinatorial cytokine expression and virusspecific cell niches within a continuum of CD8+ T cell phenotypes. Immunity 36:142-152. http://dx.doi.org/10.1016/j.immuni.2012.01.002.
8. Precopio ML, Betts MR, Parrino J, Price DA, Gostick E, Ambrozak DR, Asher TE, Douek DC, Harari A, Pantaleo G, Bailer R, Graham BS, Roederer M, Koup RA. 2007. Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8(+) T cell responses. J Exp Med 204:1405-1416. http://dx.doi.org/10.1084/jem.20062363.
9. Akondy RS, Monson ND, Miller JD, Edupuganti S, Teuwen D, Wu H, Quyyumi F, Garg S, Altman JD, Del Rio C, Keyserling HL, Ploss A, Rice CM, Orenstein WA, Mulligan MJ, Ahmed R. 2009. The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J Immunol 183:7919-7930. http://dx.doi.org/10.4049/jimmunol.0803903.
10. Co MD, Terajima M, Cruz J, Ennis FA, Rothman AL. 2002. Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology 293:151-163. http://dx.doi.org/10.1006/viro.2001.1255.
11. Turner SJ, Diaz G, Cross R, Doherty PC. 2003. Analysis of clonotype distribution and persistence for an influenza virus-specific CD8+ T cell response. Immunity 18:549-559. http://dx.doi.org/10.1016/S1074-7613(03)00087-6.
12. Blom K, Braun M, Ivarsson MA, Gonzalez VD, Falconer K, Moll M, Ljunggren HG, Michaelsson J, Sandberg JK. 2013. Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector-to a memory-type response. J Immunol 190: 2150-2158. http://dx.doi.org/10.4049/jimmunol.1202234.
13. Manuel ER, Charini WA, Sen P, Peyerl FW, Kuroda MJ, Schmitz JE, Autissier P, Sheeter DA, Torbett BE, Letvin NL. 2006. Contribution of T-cell receptor repertoire breadth to the dominance of epitope-specific CD8+ T-lymphocyte responses. J Virol 80:12032-12040. http://dx.doi.org/10.1128/JVI.01479-06.
14. Miconnet I, Marrau A, Farina A, Taffe P, Vigano S, Harari A, Pantaleo G. 2011. Large TCR diversity of virus-specific CD8 T cells provides the mechanistic basis for massive TCR renewal after antigen exposure. J Immunol 186:7039-7049. http://dx.doi.org/10.4049/jimmunol.1003309.
15. Henrickson SE, Perro M, Loughhead SM, Senman B, Stutte S, Quigley M, Alexe G, Iannacone M, Flynn MP, Omid S, Jesneck JL, Imam S, Mempel TR, Mazo IB, Haining WN, von Andrian UH. 2013. Antigen availability determines CD8(+) T cell-dendritic cell interaction kinetics and memory fate decisions. Immunity 39:496-507. http://dx.doi.org/10.1016/j.immuni.2013.08.034.
16. Ahmed R, Akondy RS. 2011. Insights into human CD8(+) T-cell memory using the yellow fever and smallpox vaccines. Immunol Cell Biol 89: 340-345. http://dx.doi.org/10.1038/icb.2010.155.
17. Achour A, Michaelsson J, Harris RA, Odeberg J, Grufman P, Sandberg JK, Levitsky V, Karre K, Sandalova T, Schneider G. 2002. A structural basis for LCMV immune evasion: subversion of H-2Db and H-2Kb presentation of gp33 revealed by comparative crystal structure analyses. Immunity 17:757-768. http://dx.doi.org/10.1016/S1074-7613(02)00478-8.
18. Eckle SB, Turner SJ, Rossjohn J, McCluskey J. 2013. Predisposed αβ T cell antigen receptor recognition of MHC and MHC-I like molecules? Curr Opin Immunol 25:653-659. http://dx.doi.org/10.1016/j.coi.2013.07.010.
19. Hou S, Hyland L, Ryan KW, Portner A, Doherty PC. 1994. Virusspecific CD8+ T-cell memory determined by clonal burst size. Nature 369:652-654. http://dx.doi.org/10.1038/369652a0.
20. Vezys V, Yates A, Casey KA, Lanier G, Ahmed R, Antia R, Masopust D. 2009. Memory CD8 T-cell compartment grows in size with immunological experience. Nature 457:196-199. http://dx.doi.org/10.1038/nature07486.
21. Badovinac VP, Porter BB, Harty JT. 2002. Programmed contraction of CD8(+) T cells after infection. Nat Immunol 3:619-626. http://dx.doi.org/10.1038/nrm880.
22. Sung JH, Zhang H, Moseman EA, Alvarez D, Iannacone M, Henrickson SE, de la Torre JC, Groom JR, Luster AD, von Andrian UH. 2012. Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Cell 150:1249-1263. http://dx.doi.org/10.1016/j.cell.2012.08.015.
23. Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, Doherty PC. 1998. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8:683-691. http://dx.doi.org/10.1016/S1074-7613(00)80573-7.
24. Sourdive DJ, Murali-Krishna K, Altman JD, Zajac AJ, Whitmire JK, Pannetier C, Kourilsky P, Evavold B, Sette A, Ahmed R. 1998. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J Exp Med 188:71-82. http://dx.doi.org/10.1084/jem.188.1.71.
25. Lee E, Lobigs M. 2008. E protein domain III determinants of yellow fever virus 17D vaccine strain enhance binding to glycosaminoglycans, impede virus spread, and attenuate virulence. J Virol 82:6024-6033. http://dx.doi.org/10.1128/JVI.02509-07.
26. SanofiPasteur. YF-VAX prospectus. Document LE6445-LE6446. SanofiPasteur, Rockville, MD.
27. Pulendran B. 2009. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat Rev Immunol 9:741-747. http://dx.doi.org/10.1038/nri2629.
28. Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, Akira S, Ahmed R, Pulendran B. 2006. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med 203:413-424. http://dx.doi.org/10.1084/jem.20051720.
29. Jonker EF, Visser LG, Roukens AH. 2013. Advances and controversies in yellow fever vaccination. Ther Adv Vaccines 1:144-152. http://dx.doi.org/10.1177/2051013613498954.
30. Reinhardt B, Jaspert R, Niedrig M, Kostner C, L'Age-Stehr J. 1998. Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. J Med Virol 56:159-167. http://dx.doi.org/10.1002/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B.
31. Santos AP, Bertho AL, Dias DC, Santos JR, Marcovistz R. 2005. Lymphocyte subset analyses in healthy adults vaccinated with yellow fever 17DD virus. Mem Inst Oswaldo Cruz 100:331-337. http://dx.doi.org/10.1590/S0074-02762005000300021.
32. Kohler S, Bethke N, Bothe M, Sommerick S, Frentsch M, Romagnani C, Niedrig M, Thiel A. 2012. The early cellular signatures of protective immunity induced by live viral vaccination. Eur J Immunol 42:2363-2373. http://dx.doi.org/10.1002/eji.201142306.
33. James EA, LaFond RE, Gates TJ, Mai DT, Malhotra U, Kwok WW. 2013. Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins. J Virol 87: 12794-12804. http://dx.doi.org/10.1128/JVI.01160-13.
34. Co MD, Kilpatrick ED, Rothman AL. 2009. Dynamics of the CD8 T-cell response following yellow fever virus 17D immunization. Immunology 128:e718-e727. http://dx.doi.org/10.1111/j.1365-2567.2009.03070.x.
35. Robins HS, Campregher PV, Srivastava SK, Wacher A, Turtle CJ, Kahsai O, Riddell SR, Warren EH, Carlson CS. 2009. Comprehensive assessment of T-cell receptor beta-chain diversity in αβ T cells. Blood 114:4099-4107. http://dx.doi.org/10.1182/blood-2009-04-217604.
36. Lefranc MP, Giudicelli V, Duroux P, Jabado-Michaloud J, Folch G, Aouinti S, Carillon E, Duvergey H, Houles A, Paysan-Lafosse T, Hadi-Saljoqi S, Sasorith S, Lefranc G, Kossida S. 2015. IMGT, the international ImMunoGeneTics information system 25 years on. Nucleic Acids Res 43:D413-D422. http://dx.doi.org/10.1093/nar/gku1056.
37. Yousfi Monod M, Giudicelli V, Chaume D, Lefranc MP. 2004. IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J junctions. Bioinformatics (Oxford) 20(Suppl 1):i379-i385. http://dx.doi.org/10.1093/bioinformatics/bth945.
38. Wu D, Emerson RO, Sherwood A, Loh ML, Angiolillo A, Howie B, Vogt J, Rieder M, Kirsch I, Carlson C, Williamson D, Wood BL, Robins H. 2014. Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGH. Clin Cancer Res 20:4540-4548. http://dx.doi.org/10.1158/1078-0432.CCR-13-3231.
39. Pulendran B, Ahmed R. 2011. Immunological mechanisms of vaccination. Nat Immunol 12:509-517. http://dx.doi.org/10.1038/ni.2039.
40. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, Miller JD, Slansky J, Ahmed R. 1998. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177-187. http://dx.doi.org/10.1016/S1074-7613(00)80470-7.
41. Hamann D, Baars PA, Rep MH, Hooibrink B, Kerkhof-Garde SR, Klein MR, van Lier RA. 1997. Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 186:1407-1418. http://dx.doi.org/10.1084/jem.186.9.1407.
42. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712. http://dx.doi.org/10.1038/44385.